SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-14-000022
Filing Date
2014-08-14
Accepted
2014-08-14 16:52:58
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-063014.htm 10-Q 583287
2 CERTIFICATION OF CEO AND CFO ex_31-1.htm EX-31.1 16252
3 CERTIFICATION OF CEO AND CFO ex_32-1.htm EX-32.1 6069
  Complete submission text file 0000318306-14-000022.txt   2742590

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE accp-20140630.xml EX-101.INS 361631
5 XBRL TAXONOMY SCHEMA accp-20140630.xsd EX-101.SCH 15207
6 XBRL TAXONOMY CALCULATION LINKBASE accp-20140630_cal.xml EX-101.CAL 33306
7 XBRL TAXONOMY DEFINITION LINKBASE accp-20140630_def.xml EX-101.DEF 85652
8 XBRL TAXONOMY LABEL LINKBASE accp-20140630_lab.xml EX-101.LAB 217227
9 XBRL TAXONOMY PRESENTATION LINKBASE accp-20140630_pre.xml EX-101.PRE 146631
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 141043868
SIC: 2834 Pharmaceutical Preparations